Kenneth J. Hillan - Chief Therapeutics Officer at 23andMe Holding Co.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Therapeutics Officer
Stock Symbol
ME on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth J. Hillan since 9/17/2023

Holdings reported by Kenneth J. Hillan for 23andMe Holding Co.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 222K $159K $0.72 Jun 5, 2023 Direct

Transactions reported by Kenneth J. Hillan for 23andMe Holding Co.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.